ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
134.71
-1.29 (-0.95%)
May 6, 2025, 4:00 PM EDT - Market closed
ICU Medical Revenue
In the year 2024, ICU Medical had annual revenue of $2.38B with 5.44% growth. ICU Medical had revenue of $629.81M in the quarter ending December 31, 2024, with 7.14% growth.
Revenue (ttm)
$2.38B
Revenue Growth
+5.44%
P/S Ratio
1.39
Revenue / Employee
$158,803
Employees
15,000
Market Cap
3.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.38B | 122.92M | 5.44% |
| Dec 31, 2023 | 2.26B | -20.87M | -0.92% |
| Dec 31, 2022 | 2.28B | 963.69M | 73.21% |
| Dec 31, 2021 | 1.32B | 45.30M | 3.56% |
| Dec 31, 2020 | 1.27B | 4.80M | 0.38% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Thermo Fisher Scientific | 42.90B |
ICUI News
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating ICU Medical, Inc. (ICUI) And Encourages Investors to Connect - Accesswire
- 2 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages ICU Medical, Inc. (ICUI) Stockholders to Inquire about Securities Investigation - Accesswire
- 4 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICU Medical, Inc. (ICUI) and Encourages Investors to Learn More About the Investigation - Accesswire
- 5 days ago - ICU Medical, Inc. (ICUI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 5 days ago - ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America - PRNewsWire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICU Medical, Inc. (ICUI) And Encourages Stockholders to Reach Out - Accesswire
- 7 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating ICU Medical, Inc. (ICUI) And Encourages Stockholders to Connect - Accesswire
- 8 days ago - ICU Medical, Inc. (ICUI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire